Literature DB >> 17230615

Depression and anxiety levels in therapy-naive patients with inflammatory bowel disease and cancer of the colon.

Branislav-R Filipović1, Branka-F Filipović, Mirko Kerkez, Nikola Milinić, Tomislav Randelović.   

Abstract

AIM: To assess whether depression and anxiety are more expressed in patients with the first episode of inflammatory bowel disease (IBD) than in individuals with newly discovered cancer of the colon (CCa).
METHODS: A total of 32 patients with IBD including 13 males and 19 females, aged 27 to 74, and 30 patients with CCa including 20 males and 10 females, aged 39-78, underwent a structured interview, which comprised Hamilton's Depression Rating Inventory, Hamilton's Anxiety Rating Inventory and Paykel's Stressful Events Rating Scale.
RESULTS: Patients of the IBD group expressed both depression and anxiety. Depressive mood, sense of guilt, psychomotor retardation and somatic anxiety were also more pronounced in IBD patients. The discriminant function analysis revealed the total depressive score was of high importance for the classification of a newly diagnosed patient into one of the groups.
CONCLUSION: Newly diagnosed patients with IBD have higher levels of depression and anxiety. Moreover, a psychiatrist in the treatment team is advisable from the beginning.

Entities:  

Mesh:

Year:  2007        PMID: 17230615      PMCID: PMC4065901          DOI: 10.3748/wjg.v13.i3.438

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  A rating scale for depression.

Authors:  M HAMILTON
Journal:  J Neurol Neurosurg Psychiatry       Date:  1960-02       Impact factor: 10.154

2.  Emotional abuse, self-blame, and self-silencing in women with irritable bowel syndrome.

Authors:  A Ali; B B Toner; N Stuckless; R Gallop; N E Diamant; M I Gould; E I Vidins
Journal:  Psychosom Med       Date:  2000 Jan-Feb       Impact factor: 4.312

Review 3.  Apoptosis and gastrointestinal pharmacology.

Authors:  D M Pritchard; A J Watson
Journal:  Pharmacol Ther       Date:  1996       Impact factor: 12.310

4.  Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys.

Authors:  Esme Fuller-Thomson; Joanne Sulman
Journal:  Inflamm Bowel Dis       Date:  2006-08       Impact factor: 5.325

5.  Depression and anxiety in people with inflammatory bowel disease.

Authors:  L M Kurina; M J Goldacre; D Yeates; L E Gill
Journal:  J Epidemiol Community Health       Date:  2001-10       Impact factor: 3.710

6.  Familial and psychological risk factors of ulcerative colitis.

Authors:  A Tocchi; L Lepre; G Liotta; G Mazzoni; G Costa; L Taborra; M Miccini
Journal:  Ital J Gastroenterol Hepatol       Date:  1997-10

Review 7.  The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review.

Authors:  E V Loftus; P Schoenfeld; W J Sandborn
Journal:  Aliment Pharmacol Ther       Date:  2002-01       Impact factor: 8.171

8.  Mortality trends of malignant tumours of digestive organs in Belgrade, Yugoslavia, 1975-1997.

Authors:  B Adanja; Z Gledovic; T Pekmezovic; H Vlajinac; M Jarebinski; V Zivaljevic; M Pavlovic
Journal:  Dig Liver Dis       Date:  2000 Jun-Jul       Impact factor: 4.088

9.  Antidepressant prescribing in community cancer care.

Authors:  Fredrick D Ashbury; Lisa Madlensky; Peter Raich; Mark Thompson; Geoff Whitney; Ken Hotz; Boris Kralj; William S Edell
Journal:  Support Care Cancer       Date:  2003-03-06       Impact factor: 3.603

10.  The relationship of current psychiatric disorder to functional disability and distress in patients with inflammatory bowel disease.

Authors:  E A Walker; M D Gelfand; A N Gelfand; F Creed; W J Katon
Journal:  Gen Hosp Psychiatry       Date:  1996-07       Impact factor: 3.238

View more
  7 in total

Review 1.  Comorbidity in inflammatory bowel disease.

Authors:  Antonio López San Román; Fernando Muñoz
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

Review 2.  Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease.

Authors:  Branislav R Filipovic; Branka F Filipovic
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

3.  Depression Is Associated With More Aggressive Inflammatory Bowel Disease.

Authors:  Bharati Kochar; Edward L Barnes; Millie D Long; Kelly C Cushing; Joseph Galanko; Christopher F Martin; Laura E Raffals; Robert S Sandler
Journal:  Am J Gastroenterol       Date:  2017-11-14       Impact factor: 10.864

4.  Important relation between self-efficacy, sense of coherence, illness perceptions, depression and anxiety in patients with inflammatory bowel disease.

Authors:  Adi Eindor-Abarbanel; Timna Naftali; Nahum Ruhimovich; Ariella Bar-Gil Shitrit; Fabiana Sklerovsky-Benjaminov; Fred Konikoff; Shay Matalon; Haim Shirin; Yael Milgrom; Tomer Ziv-Baran; Efrat Broide
Journal:  Frontline Gastroenterol       Date:  2020-08-25

Review 5.  Inflammatory bowel diseases and human reproduction: a comprehensive evidence-based review.

Authors:  Stefano Palomba; Giuliana Sereni; Angela Falbo; Marina Beltrami; Silvia Lombardini; Maria Chiara Boni; Giovanni Fornaciari; Romano Sassatelli; Giovanni Battista La Sala
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

6.  Illness perceptions and stress: mediators between disease severity and psychological well-being and quality of life among patients with Crohn's disease.

Authors:  Maochen Zhang; Liwen Hong; Tianyu Zhang; Yun Lin; Sichang Zheng; Xiaolin Zhou; Rong Fan; Zhengting Wang; Chenli Zhang; Jie Zhong
Journal:  Patient Prefer Adherence       Date:  2016-11-23       Impact factor: 2.711

7.  Efficacy of duloxetine add on in treatment of inflammatory bowel disease patients: A double-blind controlled study.

Authors:  Hamed Daghaghzadeh; Fateme Naji; Hamid Afshar; Mohammad Reza Sharbafchi; Awat Feizi; Mohsen Maroufi; Mahshid Tabatabaeeyan; Peyman Adibi; Hamid Tavakoli
Journal:  J Res Med Sci       Date:  2015-06       Impact factor: 1.852

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.